Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marianne T, Bjerre"'
Autor:
Maibritt Nørgaard, Marianne T Bjerre, Jacob Fredsøe, Søren Vang, Jørgen B Jensen, Bram De Laere, Henrik Grönberg, Michael Borre, Johan Lindberg, Karina D Sørensen
Publikováno v:
Nørgaard, M, Bjerre, M T, Fredsøe, J, Vang, S, Jensen, J B, De Laere, B, Grönberg, H, Borre, M, Lindberg, J & Sørensen, K D 2023, ' Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer ', Clinical Chemistry, vol. 69, no. 4, pp. 386-398 . https://doi.org/10.1093/clinchem/hvac224
Background Multiple treatments are available for metastatic castration-resistant prostate cancer (mCRPC), including androgen receptor signaling inhibitors (ARSI) enzalutamide and abiraterone, but therapy resistance remains a major clinical obstacle.
Autor:
Jacob Fredsøe, Anne K. I. Rasmussen, Peter Mouritzen, Marianne T. Bjerre, Peter Østergren, Mikkel Fode, Michael Borre, Karina D. Sørensen
Publikováno v:
Diagnostics, Vol 10, Iss 4, p 188 (2020)
Early detection of prostate cancer (PC) is paramount as localized disease is generally curable, while metastatic PC is generally incurable. There is a need for improved, minimally invasive biomarkers as current diagnostic tools are inaccurate, leadin
Externí odkaz:
https://doaj.org/article/7678c08bdc47405e9fa88a341113712b
Autor:
Marianne T, Bjerre, Siri H, Strand, Maibritt, Nørgaard, Helle, Kristensen, Anne Ki, Rasmussen, Martin Mørck, Mortensen, Jacob, Fredsøe, Peter, Mouritzen, Benedicte, Ulhøi, Torben, Ørntoft, Michael, Borre, Karina D, Sørensen
Publikováno v:
International Journal of Molecular Sciences
Prostate cancer (PCa) is a clinically heterogeneous disease and currently, accurate diagnostic and prognostic molecular biomarkers are lacking. This study aimed to identify novel DNA hypermethylation markers for PCa with future potential for blood-ba